Log In
Print
BCIQ
Print
Print this Print this
 

Aerospan, flunisolide HFA

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionHydrofluoroalkane (HFA)-propelled inhaled formulation of flunisolide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat mild persistent asthma
Regulatory Designation
Partner Meda AB

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$200.0M

$135.0M

$65.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today